Citigroup’s Qiagen QGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $55.5M | Sell |
1,385,111
-25,825
| -2% | -$1.22M | 0.02% | 601 |
|
|
2025
Q4 | $63.4M | Buy |
1,410,936
+1,173,007
| +493% | +$54.3M | 0.03% | 550 |
|
|
2025
Q3 | $10.6M | Sell |
237,929
-184,808
| -44% | -$8.84M | ﹤0.01% | 1446 |
|
|
2025
Q2 | $20.3M | Sell |
422,737
-50,651
| -11% | -$2.2M | 0.01% | 951 |
|
|
2025
Q1 | $18.8M | Buy |
473,388
+169,482
| +56% | +$7.13M | 0.01% | 1012 |
|
|
2024
Q4 | $13.9M | Sell |
303,906
-94,400
| -24% | -$4.23M | 0.01% | 1174 |
|
|
2024
Q3 | $18.5M | Sell |
398,306
-1,004,588
| -72% | -$45.8M | 0.01% | 981 |
|
|
2024
Q2 | $59.6M | Sell |
1,402,894
-15,293
| -1% | -$671K | 0.04% | 429 |
|
|
2024
Q1 | $62.4M | Buy |
1,418,187
+86,863
| +7% | +$3.96M | 0.04% | 394 |
|
|
2023
Q4 | $61.4M | Buy |
1,331,324
+725,252
| +120% | +$30.8M | 0.04% | 380 |
|
|
2023
Q3 | $26M | Buy |
606,072
+123,844
| +26% | +$5.77M | 0.02% | 670 |
|
|
2023
Q2 | $23M | Sell |
482,228
-1,053,405
| -69% | -$50.8M | 0.02% | 759 |
|
|
2023
Q1 | $74.1M | Buy |
1,535,633
+780,412
| +103% | +$39.7M | 0.05% | 291 |
|
|
2022
Q4 | $39.9M | Buy |
755,221
+274,660
| +57% | +$13.5M | 0.03% | 481 |
|
|
2022
Q3 | $21M | Sell |
480,561
-431,078
| -47% | -$21.3M | 0.02% | 763 |
|
|
2022
Q2 | $45.6M | Sell |
911,639
-30,422
| -3% | -$1.48M | 0.03% | 412 |
|
|
2022
Q1 | $48.9M | Buy |
942,061
+96,212
| +11% | +$4.97M | 0.03% | 513 |
|
|
2021
Q4 | $49.9M | Buy |
845,849
+374,898
| +80% | +$21.5M | 0.03% | 563 |
|
|
2021
Q3 | $25.8M | Sell |
470,951
-19,757
| -4% | -$1.1M | 0.02% | 851 |
|
|
2021
Q2 | $25.2M | Sell |
490,708
-174,079
| -26% | -$8.99M | 0.02% | 873 |
|
|
2021
Q1 | $34.3M | Sell |
664,787
-1,937,236
| -74% | -$106M | 0.02% | 672 |
|
|
2020
Q4 | $146M | Buy |
2,602,023
+1,728,502
| +198% | +$92.2M | 0.09% | 210 |
|
|
2020
Q3 | $48.4M | Sell |
873,521
-8,742,192
| -91% | -$453M | 0.03% | 466 |
|
|
2020
Q2 | $437M | Buy |
9,615,713
+4,326,414
| +82% | +$194M | 0.34% | 39 |
|
|
2020
Q1 | $233M | Buy |
5,289,299
+4,793,253
| +966% | +$187M | 0.21% | 71 |
|
|
2019
Q4 | $17.8M | Buy |
496,046
+90,670
| +22% | +$3.37M | 0.01% | 1051 |
|
|
2019
Q3 | $14.2M | Sell |
405,376
-34,761
| -8% | -$1.34M | 0.01% | 1156 |
|
|
2019
Q2 | $18.9M | Buy |
440,137
+55,235
| +14% | +$2.29M | 0.02% | 965 |
|
|
2019
Q1 | $16.6M | Buy |
384,902
+1,987
| +0.5% | +$79.9K | 0.02% | 948 |
|
|
2018
Q4 | $14M | Sell |
382,915
-57,591
| -13% | -$2.14M | 0.01% | 1034 |
|
|
2018
Q3 | $17.7M | Buy |
440,506
+109,483
| +33% | +$4.37M | 0.02% | 910 |
|
|
2018
Q2 | $12.7M | Buy |
331,023
+77,939
| +31% | +$2.87M | 0.01% | 1107 |
|
|
2018
Q1 | $8.67M | Sell |
253,084
-43,484
| -15% | -$1.53M | 0.01% | 1346 |
|
|
2017
Q4 | $9.73M | Buy |
296,568
+83,119
| +39% | +$2.86M | 0.01% | 1312 |
|
|
2017
Q3 | $7.13M | Buy |
213,449
+30,611
| +17% | +$1.05M | 0.01% | 1469 |
|
|
2017
Q2 | $6.5M | Buy |
182,838
+1,734
| +1% | +$58.6K | 0.01% | 1478 |
|
|
2017
Q1 | $5.56M | Buy |
+181,104
| New | +$5.58M | 0.01% | 1576 |
|
Other funds holding QGEN
VCM
Citigroup's QGEN Position: Q1 2026 in Review
Citigroup reduced its Qiagen (QGEN) stake by 1.8% in Q1 2026, selling an estimated $1.22M and leaving 1,385,111 shares worth $55.5M. The position accounts for 0.02% of the portfolio, ranked #601.
Citigroup first reported a position in QGEN in Q1 2017 and has held it in 37 quarters since. The position peaked at $437M in Q2 2020. 343 funds tracked by Wall St. Rank hold QGEN as of Q1 2026.
- Citigroup held 1,385,111 shares of Qiagen worth $55.5M as of Q1 2026.
- Citigroup sold 25,825 Qiagen shares in Q1 2026, an estimated $1.22M.
- Qiagen made up 0.02% of Citigroup's portfolio in Q1 2026, its #601 holding.
- Citigroup first reported a position in Qiagen in Q1 2017 and has held it in 37 quarters since.
- Citigroup's Qiagen position peaked at $437M in Q2 2020.
- 343 funds tracked by Wall St. Rank held Qiagen as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.